# Genesis BioCapital Fund I, LP — Form D/A

Genesis BioCapital Fund I, LP of CHATTANOOGA, TN, a pooled investment fund, filed a Form D amendment with the SEC on 2026-01-23. $18.5M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2026-01-23
- Form: D/A
- Accession: 0001493152-26-003327
- Industry: Pooled Investment Fund
- Exemptions: 06b,3C,3C.7
- Amount sold: $18.5M
- Investors: 21
- Date of first sale: 2025-01-24
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-536080

## Issuer

- Name: Genesis BioCapital Fund I, LP
- CIK: 0002053141
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 200 WEST MLK BLVD., CHATTANOOGA, TN, 37402
- Phone: 617-444-8400

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| - Genesis BioCapital Fund I GP, LP | Related Person | Chattanooga, TN |
| - Genesis BioCapital Management, LLC | Related Person | Chattanooga, TN |
| Ray Tabibiazar | Related Person | Chattanooga, TN |
| Ray Tabibiazar | Executive Officer | Chattanooga, TN |
| - Genesis BioCapital Management, LLC | Executive Officer | Chattanooga, TN |
| - Genesis BioCapital Fund I GP, LP | Executive Officer | Chattanooga, TN |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-01-23](https://search.stillhousedata.com/formd/0001493152-25-003393) | D | — | — |

## More

- [CIK 2053141 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2053141&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001493152-26-003327.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.